ICICI Prudential Nifty Pharma Index Fund vs Mirae Asset Nifty 500 Healthcare ETF
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
ICICI Prudential Nifty Pharma Index Fund is an Index fund and Mirae Asset Nifty 500 Healthcare ETF is an ETF fund. ICICI Prudential Nifty Pharma Index Fund charges 0.51% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%. Their portfolios overlap 69.0%: they hold 20 of the same securities.
ICICI Prudential Nifty Pharma Index Fund
Index
- Expense ratio
- 0.51%
- NAV
- ₹21.00
Mirae Asset Nifty 500 Healthcare ETF
ETF
- Expense ratio
- 0.35%
- NAV
- ₹21.44
Which is better, ICICI Prudential Nifty Pharma Index or Mirae Asset Nifty 500 Healthcare ETF? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Mirae Asset Nifty 500 Healthcare ETF costs less: 0.35% a year against 0.51%.
- ICICI Prudential Nifty Pharma Index fell less in its worst fall since 11-02-2026: −6.9% against −9.6%.
- ICICI Prudential Nifty Pharma Index holds more in large companies: 46.3% of the fund in large caps against 36.0%.
- ICICI Prudential Nifty Pharma Index is the larger fund: ₹163 Cr against ₹15 Cr.
- Their portfolios overlap 69.0%: 20 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | ICICI Prudential Nifty Pharma Index Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Fund house | ICICI Prudential Mutual Fund | Mirae Asset Mutual Fund |
| Category | Index | ETF |
| AUM | ₹163 Cr (30-09-2026) | ₹15 Cr (30-09-2026) |
| NAV | ₹21.00 (Direct) | ₹21.44 |
| Expense ratio (Direct) | 0.51% | Not available |
| Expense ratio (Regular) | 1.13% | Not available |
| Riskometer | Not available | Very High |
| Benchmark | Nifty Pharma TRI | Nifty500 Healthcare TRI |
| Launch date | 14-12-2022 | Not available |
| Minimum investment | ₹1,000 | On exchange in multiple of 1 unit. With AMC: In multiples of 5,000 units |
| Lock in | None | None |
| Fund managers | Nishit Patel, Ashwini Bharucha, Venus Ahuja | Ekta Gala, amp, Ritesh Patel |
| Exit load | Nil | NIL |
ICICI Prudential Nifty Pharma Index vs Mirae Asset Nifty 500 Healthcare ETF: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund (Direct) | +2.56% | +2.91% | +16.72% | +21.78% | +22.52% | -- | -- |
| Mirae Asset Nifty 500 Healthcare ETF | +1.43% | −0.66% | +12.95% | -- | -- | -- | -- |
ICICI Prudential Nifty Pharma Index vs Mirae Asset Nifty 500 Healthcare ETF: Year-wise Returns
| Year | ICICI Prudential Nifty Pharma IndexICICI Prudential Nifty Pharma Index | Mirae Asset Nifty 500 Healthcare ETFMirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| 2026to date | +19.57% | -- |
| 2025 | −2.59% | -- |
| 2024 | +38.82% | -- |
| 2023 | +32.85% | -- |
ICICI Prudential Nifty Pharma Index vs Mirae Asset Nifty 500 Healthcare ETF: Rolling Returns
Every holding period of both funds, against Nifty Pharma TRI, the benchmark of ICICI Prudential Nifty Pharma Index Fund
ICICI Prudential Nifty Pharma Index vs Mirae Asset Nifty 500 Healthcare ETF: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | ICICI Prudential Nifty Pharma Index Fund (Direct) | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Return (CAGR) | +21.29% | +23.46% |
| Standard deviation | 14.33% | 14.16% |
| Sharpe ratio | 1.05 | 1.29 |
| Sortino ratio | 1.55 | 1.90 |
| Maximum drawdown | −16.6% (28-02-2025) | −9.6% (23-10-2026) |
| Beta | 1.00 | 1.00 |
| Alpha | −0.92% | −0.22% |
From daily NAVs, 15-12-2022 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
ICICI Prudential Nifty Pharma Index Fund (Direct)
Mirae Asset Nifty 500 Healthcare ETF
Nifty Pharma TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund (Direct) | −6.9% | 31-08-2026 | 23-10-2026 | Not yet | -- | −0.3% |
| Mirae Asset Nifty 500 Healthcare ETF | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| Nifty Pharma TRI | −6.8% | 31-08-2026 | 23-10-2026 | Not yet | -- | −0.2% |
From daily values since 11-02-2026, the first day every fund has.
ICICI Prudential Nifty Pharma Index vs Mirae Asset Nifty 500 Healthcare ETF: Portfolio Overlap
From each fund's latest monthly portfolio: ICICI Prudential Nifty Pharma Index Fund, September 2026; Mirae Asset Nifty 500 Healthcare ETF, September 2026
Holdings in common
- Overlap
- 69.0%
- Held by both
- 20
- Only in ICICI Prudential Nifty Pharma Index
- 0
- Only in Mirae Asset Nifty 500 Healthcare ETF
- 24
| Security | % of ICICI Prudential Nifty Pharma Index | % of Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 19.50% | 10.13% |
| Divi's Laboratories Ltd. | 11.97% | 8.76% |
| Laurus Labs Ltd. | 7.82% | 5.72% |
| Cipla Ltd. | 7.68% | 5.62% |
| Dr. Reddy's Laboratories Ltd. | 7.62% | 5.58% |
| Torrent Pharmaceuticals Ltd. | 7.16% | 5.24% |
| Lupin Ltd. | 5.00% | 3.66% |
| Aurobindo Pharma Ltd. | 4.68% | 3.43% |
| Glenmark Pharmaceuticals Ltd. | 3.56% | 2.61% |
| Alkem Laboratories Ltd. | 3.16% | 2.31% |
| Zydus Lifesciences Ltd. | 2.92% | 2.14% |
| Mankind Pharma Ltd. | 2.88% | 2.10% |
| IPCA Laboratories Ltd. | 2.71% | 1.98% |
| Biocon Ltd. | 2.62% | 1.91% |
| Gland Pharma Ltd. | 2.34% | 1.71% |
| Sai Life Sciences Ltd. | 2.14% | 1.56% |
| Wockhardt Ltd. | 1.77% | 1.30% |
| Ajanta Pharma Ltd. | 1.67% | 1.22% |
| Abbott India Ltd. | 1.43% | 1.04% |
| Piramal Pharma Ltd. | 1.30% | 0.95% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 69.0% means 69.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in ICICI Prudential Nifty Pharma Index Fund
Every holding of this fund is also held by the other.
Largest holdings only in Mirae Asset Nifty 500 Healthcare ETF
| Security | % of fund |
|---|---|
| Apollo Hospitals Enterprise Ltd. | 6.24% |
| Max Healthcare Institute Ltd. | 5.13% |
| Fortis Healthcare Ltd. | 2.98% |
| Krishna Institute of Medical Sciences Ltd. | 1.48% |
| Aster DM Quality Care Ltd. | 1.38% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | ICICI Prudential Nifty Pharma Index | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Equity | 99.9% | 100.0% |
| Debt | 0.0% | 0.0% |
| Cash and others | 0.1% | 0.0% |
Market cap of stocks
| Market cap | ICICI Prudential Nifty Pharma Index | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Large Cap | 46.3% | 36.0% |
| Mid Cap | 46.1% | 45.6% |
| Small Cap | 7.5% | 18.3% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | ICICI Prudential Nifty Pharma Index | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Pharmaceuticals & Biotechnology | 99.9% | 77.8% |
| Healthcare Services | 0.0% | 21.7% |
| Healthcare Equipment & Supplies | 0.0% | 0.5% |
The six largest sectors of each fund's stocks, % of the fund.
ICICI Prudential Nifty Pharma Index vs Mirae Asset Nifty 500 Healthcare ETF: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | ICICI Prudential Nifty Pharma Index Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Total expense ratio (Direct) | 0.51% | Not available |
| Base expense ratio (Direct) | 0.32% | 0.00% |
| Total expense ratio (Regular) | 1.13% | Not available |
| Base expense ratio (Regular) | 0.85% | 0.16% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
ICICI Prudential Nifty Pharma Index Fund vs Mirae Asset Nifty 500 Healthcare ETF: Frequently Asked Questions
What is the difference between ICICI Prudential Nifty Pharma Index Fund and Mirae Asset Nifty 500 Healthcare ETF?
ICICI Prudential Nifty Pharma Index Fund is an Index fund, Mirae Asset Nifty 500 Healthcare ETF is an ETF fund, run by ICICI Prudential Mutual Fund and Mirae Asset Mutual Fund. Their portfolios overlap 69.0%. ICICI Prudential Nifty Pharma Index Fund charges 0.51% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%.
Which has the lower expense ratio, ICICI Prudential Nifty Pharma Index Fund or Mirae Asset Nifty 500 Healthcare ETF?
Mirae Asset Nifty 500 Healthcare ETF charges less: 0.35% a year against 0.51%. These are the total expense ratios reported to AMFI.
How much do ICICI Prudential Nifty Pharma Index Fund and Mirae Asset Nifty 500 Healthcare ETF overlap?
69.0%. They hold 20 of the same securities, the largest shared ones being SUNPHARMA, DIVISLAB, LAURUSLABS. From each fund's latest monthly portfolio.
Can I invest in both ICICI Prudential Nifty Pharma Index Fund and Mirae Asset Nifty 500 Healthcare ETF?
Yes. 69.0% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages ICICI Prudential Nifty Pharma Index Fund and Mirae Asset Nifty 500 Healthcare ETF?
ICICI Prudential Nifty Pharma Index Fund: Nishit Patel, Ashwini Bharucha, Venus Ahuja. Mirae Asset Nifty 500 Healthcare ETF: Ekta Gala, amp, Ritesh Patel.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.